PubMed:24037315 / 835-999 JSONTXT

Annnotations TAB JSON ListView MergeView

    PubMed_ArguminSci

    {"project":"PubMed_ArguminSci","denotations":[{"id":"T7","span":{"begin":0,"end":115},"obj":"DRI_Outcome"},{"id":"T8","span":{"begin":143,"end":164},"obj":"DRI_Outcome"}],"text":"Nevertheless, activation of extracellular signal-regulated kinase (ERK)1/2 or protein kinase B (AKT) was reduced in ∼20-week C57BL/6 MMTV-PyMT tumors lacking MGAT3."}

    sentences

    {"project":"sentences","denotations":[{"id":"TextSentencer_T6","span":{"begin":0,"end":164},"obj":"Sentence"},{"id":"T6","span":{"begin":0,"end":164},"obj":"Sentence"},{"id":"T6","span":{"begin":0,"end":164},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Nevertheless, activation of extracellular signal-regulated kinase (ERK)1/2 or protein kinase B (AKT) was reduced in ∼20-week C57BL/6 MMTV-PyMT tumors lacking MGAT3."}

    PubmedHPO

    {"project":"PubmedHPO","denotations":[{"id":"T7","span":{"begin":143,"end":149},"obj":"HP_0002664"}],"text":"Nevertheless, activation of extracellular signal-regulated kinase (ERK)1/2 or protein kinase B (AKT) was reduced in ∼20-week C57BL/6 MMTV-PyMT tumors lacking MGAT3."}

    GlycoBiology-FMA

    {"project":"GlycoBiology-FMA","denotations":[{"id":"_T21","span":{"begin":78,"end":85},"obj":"FMAID:67257"},{"id":"_T22","span":{"begin":78,"end":85},"obj":"FMAID:165447"}],"namespaces":[{"prefix":"FMAID","uri":"http://purl.org/sig/ont/fma/fma"}],"text":"Nevertheless, activation of extracellular signal-regulated kinase (ERK)1/2 or protein kinase B (AKT) was reduced in ∼20-week C57BL/6 MMTV-PyMT tumors lacking MGAT3."}

    uniprot-human

    {"project":"uniprot-human","denotations":[{"id":"T4","span":{"begin":158,"end":163},"obj":"http://www.uniprot.org/uniprot/Q86VF5"},{"id":"T10","span":{"begin":158,"end":163},"obj":"http://www.uniprot.org/uniprot/Q09327"},{"id":"T13","span":{"begin":59,"end":72},"obj":"http://www.uniprot.org/uniprot/Q02750"},{"id":"T14","span":{"begin":59,"end":72},"obj":"http://www.uniprot.org/uniprot/P45985"},{"id":"T15","span":{"begin":67,"end":70},"obj":"http://www.uniprot.org/uniprot/P29323"},{"id":"T16","span":{"begin":67,"end":72},"obj":"http://www.uniprot.org/uniprot/P27361"},{"id":"T17","span":{"begin":73,"end":92},"obj":"http://www.uniprot.org/uniprot/Q05397"}],"text":"Nevertheless, activation of extracellular signal-regulated kinase (ERK)1/2 or protein kinase B (AKT) was reduced in ∼20-week C57BL/6 MMTV-PyMT tumors lacking MGAT3."}

    uniprot-mouse

    {"project":"uniprot-mouse","denotations":[{"id":"T3","span":{"begin":67,"end":72},"obj":"http://www.uniprot.org/uniprot/Q63844"}],"text":"Nevertheless, activation of extracellular signal-regulated kinase (ERK)1/2 or protein kinase B (AKT) was reduced in ∼20-week C57BL/6 MMTV-PyMT tumors lacking MGAT3."}

    GO-BP

    {"project":"GO-BP","denotations":[{"id":"T3","span":{"begin":42,"end":48},"obj":"http://purl.obolibrary.org/obo/GO_0023052"},{"id":"T6","span":{"begin":14,"end":48},"obj":"http://purl.obolibrary.org/obo/GO_0070266"},{"id":"T7","span":{"begin":14,"end":65},"obj":"http://purl.obolibrary.org/obo/GO_0004707"},{"id":"T8","span":{"begin":28,"end":58},"obj":"http://purl.obolibrary.org/obo/GO_1900115"},{"id":"T9","span":{"begin":42,"end":58},"obj":"http://purl.obolibrary.org/obo/GO_0023051"},{"id":"T10","span":{"begin":42,"end":65},"obj":"http://purl.obolibrary.org/obo/GO_0010738"},{"id":"T11","span":{"begin":49,"end":58},"obj":"http://purl.obolibrary.org/obo/GO_0065007"},{"id":"T12","span":{"begin":67,"end":70},"obj":"http://purl.obolibrary.org/obo/GO_0004707"},{"id":"T13","span":{"begin":78,"end":94},"obj":"http://purl.obolibrary.org/obo/GO_0032148"},{"id":"T14","span":{"begin":78,"end":94},"obj":"http://purl.obolibrary.org/obo/GO_0043491"}],"text":"Nevertheless, activation of extracellular signal-regulated kinase (ERK)1/2 or protein kinase B (AKT) was reduced in ∼20-week C57BL/6 MMTV-PyMT tumors lacking MGAT3."}

    GO-MF

    {"project":"GO-MF","denotations":[{"id":"T5","span":{"begin":78,"end":94},"obj":"http://purl.obolibrary.org/obo/GO_0043422"}],"text":"Nevertheless, activation of extracellular signal-regulated kinase (ERK)1/2 or protein kinase B (AKT) was reduced in ∼20-week C57BL/6 MMTV-PyMT tumors lacking MGAT3."}

    GO-CC

    {"project":"GO-CC","denotations":[{"id":"T4","span":{"begin":28,"end":41},"obj":"http://purl.obolibrary.org/obo/GO_0005576"}],"text":"Nevertheless, activation of extracellular signal-regulated kinase (ERK)1/2 or protein kinase B (AKT) was reduced in ∼20-week C57BL/6 MMTV-PyMT tumors lacking MGAT3."}

    EDAM-topics

    {"project":"EDAM-topics","denotations":[{"id":"T8","span":{"begin":78,"end":85},"obj":"http://edamontology.org/topic_0078"}],"text":"Nevertheless, activation of extracellular signal-regulated kinase (ERK)1/2 or protein kinase B (AKT) was reduced in ∼20-week C57BL/6 MMTV-PyMT tumors lacking MGAT3."}

    EDAM-DFO

    {"project":"EDAM-DFO","denotations":[{"id":"T3","span":{"begin":78,"end":85},"obj":"http://edamontology.org/data_1467"},{"id":"T4","span":{"begin":78,"end":85},"obj":"http://edamontology.org/format_1208"}],"text":"Nevertheless, activation of extracellular signal-regulated kinase (ERK)1/2 or protein kinase B (AKT) was reduced in ∼20-week C57BL/6 MMTV-PyMT tumors lacking MGAT3."}

    Allie

    {"project":"Allie","denotations":[{"id":"SS1_24037315_5_0","span":{"begin":28,"end":65},"obj":"expanded"},{"id":"SS2_24037315_5_0","span":{"begin":67,"end":70},"obj":"abbr"}],"relations":[{"id":"AE1_24037315_5_0","pred":"abbreviatedTo","subj":"SS1_24037315_5_0","obj":"SS2_24037315_5_0"}],"text":"Nevertheless, activation of extracellular signal-regulated kinase (ERK)1/2 or protein kinase B (AKT) was reduced in ∼20-week C57BL/6 MMTV-PyMT tumors lacking MGAT3."}

    mondo_disease

    {"project":"mondo_disease","denotations":[{"id":"T9","span":{"begin":143,"end":149},"obj":"Disease"}],"attributes":[{"id":"A9","pred":"mondo_id","subj":"T9","obj":"http://purl.obolibrary.org/obo/MONDO_0005070"}],"text":"Nevertheless, activation of extracellular signal-regulated kinase (ERK)1/2 or protein kinase B (AKT) was reduced in ∼20-week C57BL/6 MMTV-PyMT tumors lacking MGAT3."}

    NCBITAXON

    {"project":"NCBITAXON","denotations":[{"id":"T9","span":{"begin":133,"end":137},"obj":"OrganismTaxon"}],"attributes":[{"id":"A9","pred":"db_id","subj":"T9","obj":"11757"}],"text":"Nevertheless, activation of extracellular signal-regulated kinase (ERK)1/2 or protein kinase B (AKT) was reduced in ∼20-week C57BL/6 MMTV-PyMT tumors lacking MGAT3."}

    Anatomy-UBERON

    {"project":"Anatomy-UBERON","denotations":[{"id":"T4","span":{"begin":28,"end":41},"obj":"Body_part"}],"attributes":[{"id":"A4","pred":"uberon_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/GO_0005576"}],"text":"Nevertheless, activation of extracellular signal-regulated kinase (ERK)1/2 or protein kinase B (AKT) was reduced in ∼20-week C57BL/6 MMTV-PyMT tumors lacking MGAT3."}